InvestorsHub Logo
Followers 25
Posts 2345
Boards Moderated 0
Alias Born 06/20/2020

Re: C-20 post# 160259

Tuesday, 04/20/2021 2:47:53 PM

Tuesday, April 20, 2021 2:47:53 PM

Post# of 233066

The trial was a success by the simple fact we completed it as we are the only company to take on S2C patients with mortality as the endpoint.


So the trial was a success because you completed it and had mortality as an endpoint?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News